pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
SENT-001
Fallopian Tube Cancer
Sentinel BioTherapeutics Inc
0 catalysts
Phase 2
SGB-9768
Membranoproliferative Glomerulonephritis (Mesangiocapillary Glomerulonephritis)
Sanegene Bio USA Inc
0 catalysts
Phase 2
SGN-1
Metastatic Hepatocellular Carcinoma (HCC)
Guangzhou Huajin Pharmaceutical Technology Co Ltd
0 catalysts
Phase 2
SGT-003
Duchenne Muscular Dystrophy
← prev
page 25 of 50
next →
131
Pain89
Neurology1
$SLDBSolid Biosciences Inc.
0 catalysts
Phase 2
SGT-212
Friedreich Ataxia
$SLDBSolid Biosciences Inc.
0 catalysts
Phase 2
SGX-945
dusquetide
Aphthous Ulcers (Canker Sores)
$SNGXSOLIGENIX, INC.
0 catalysts
Phase 2
SHJ-002
Myopia
Sunhawk Vision Biotech Inc
0 catalysts
Phase 2
SHR-4849
Neuroendocrine Tumors
$IDYAIDEAYA Biosciences, Inc.
0 catalysts
Phase 2
SI-006
Irritable Bowel Syndrome
Shanghai Pharmaceuticals Holding Co Ltd
0 catalysts
Phase 2
SI-101
Non-Hodgkin Lymphoma
BobcatBio Inc
0 catalysts
Phase 2
SI-722
Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome)
Seikagaku Corp
0 catalysts
Phase 2
SION-719
Cystic Fibrosis
$SIONSionna Therapeutics, Inc.
0 catalysts
Phase 2
SIP-104
Lorexys ((bupropion hydrochloride + trazodone hydrochloride))
Female Hypoactive Sexual Desire Disorder
S1 Biopharma Inc
0 catalysts
Phase 2
SKG-0106
Wet (Neovascular / Exudative) Macular Degeneration
Skyline Therapeutics (Shanghai) Co Ltd
0 catalysts
Phase 2
SL-701
Recurrent Glioblastoma Multiforme (GBM)
Stemline Therapeutics Inc
0 catalysts
Phase 2
SLIF-06
Hypertrophic Scars
Scarless Laboratories Inc
0 catalysts
Phase 2
SMART-101
Refractory Acute Myeloid Leukemia
Smart Immune SAS
0 catalysts
Phase 2
SMP-3124
Anal Cancer
Sumitomo Pharma Co Ltd
0 catalysts
Phase 2
SN-514
Burns
SERDA Therapeutics BV
0 catalysts
Phase 2
SNB-011
Pentarlandir
Coronavirus Disease 2019 (COVID-19)
SyneuRx International (Taiwan) Corp
0 catalysts
Phase 2
SND-51
Dementia
SyneuRx International (Taiwan) Corp
0 catalysts
Phase 2
SNIPR-001
Escherichia coli Infections
SNIPR Biome ApS
0 catalysts
Phase 2
SNP-610
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Sinew Pharma Inc
0 catalysts
Phase 2
SNS-812
Coronavirus Disease 2019 (COVID-19)
Oneness Biotech Co Ltd
0 catalysts
Phase 2
SP-0230
Neisseria meningitidis Infections
$SNYSanofi
0 catalysts
Phase 2
SP-0256
Human Metapneumovirus Infections
$SNYSanofi
0 catalysts
Phase 2
SP-0269
Chlamydia trachomatis Infections
$SNYSanofi
0 catalysts
Phase 2
SP-101
Cystic Fibrosis
Spirovant Sciences Inc
0 catalysts
Phase 2
SPG-601
Fragile X Syndrome
Spinogenix Inc
0 catalysts
Phase 2
SPL-84
Cystic Fibrosis
SpliSense Ltd
0 catalysts